Brett E Fortune
@brettefortune.bsky.social
Chief Medical Officer, Miami Transplant Institute, Transplant Hepatologist, likes interventional hepatology, cirrhosis, portal hypertension #LiverSky #JacksonHealth
Reposted by Brett E Fortune
🚀 Attention #AASLD members!
Do you have a passion for clinical informatics & digital health? Or interested in learning more about how this new field can improve hepatology patient care and research? A new Special Interest Group (SIG) may be on the horizon… 👀
Do you have a passion for clinical informatics & digital health? Or interested in learning more about how this new field can improve hepatology patient care and research? A new Special Interest Group (SIG) may be on the horizon… 👀
August 17, 2025 at 7:48 PM
🚀 Attention #AASLD members!
Do you have a passion for clinical informatics & digital health? Or interested in learning more about how this new field can improve hepatology patient care and research? A new Special Interest Group (SIG) may be on the horizon… 👀
Do you have a passion for clinical informatics & digital health? Or interested in learning more about how this new field can improve hepatology patient care and research? A new Special Interest Group (SIG) may be on the horizon… 👀
Reposted by Brett E Fortune
We’re proposing a Clinical Informatics & Digital Health SIG to bring together members interested in EHR optimization, AI, clinical decision support, data science, mentorship & more.
👉 If the SIG is approved, would you join? Send me a chat for details!
#AASLD
👉 If the SIG is approved, would you join? Send me a chat for details!
#AASLD
August 17, 2025 at 7:49 PM
We’re proposing a Clinical Informatics & Digital Health SIG to bring together members interested in EHR optimization, AI, clinical decision support, data science, mentorship & more.
👉 If the SIG is approved, would you join? Send me a chat for details!
#AASLD
👉 If the SIG is approved, would you join? Send me a chat for details!
#AASLD
Reposted by Brett E Fortune
Exploring further the agreement between HVPG and EUS-PPG a collaborative study with Leuven. www.jhep-reports.eu/article/S258... @idibaps.bsky.social @hospitalclinic.bsky.social
www.jhep-reports.eu
July 12, 2025 at 6:51 AM
Exploring further the agreement between HVPG and EUS-PPG a collaborative study with Leuven. www.jhep-reports.eu/article/S258... @idibaps.bsky.social @hospitalclinic.bsky.social
Reposted by Brett E Fortune
🆕CPG in press❕
EASL Clinical Practice Guidelines on extrahepatic abdominal surgery in patients with cirrhosis and advanced chronic liver disease
Find it here👉https://bit.ly/3GM9EEB
#LiverSky
@easlnews.bsky.social
EASL Clinical Practice Guidelines on extrahepatic abdominal surgery in patients with cirrhosis and advanced chronic liver disease
Find it here👉https://bit.ly/3GM9EEB
#LiverSky
@easlnews.bsky.social
May 10, 2025 at 6:05 AM
🆕CPG in press❕
EASL Clinical Practice Guidelines on extrahepatic abdominal surgery in patients with cirrhosis and advanced chronic liver disease
Find it here👉https://bit.ly/3GM9EEB
#LiverSky
@easlnews.bsky.social
EASL Clinical Practice Guidelines on extrahepatic abdominal surgery in patients with cirrhosis and advanced chronic liver disease
Find it here👉https://bit.ly/3GM9EEB
#LiverSky
@easlnews.bsky.social
Reposted by Brett E Fortune
Highlights of @docberza.bsky.social talk on NITs @easlnews.bsky.social #easlcongress
We need to use @bavenocoop.bsky.social
dual stiffness cutoffs more often and u suspect this is the way of the future.
#liversky
We need to use @bavenocoop.bsky.social
dual stiffness cutoffs more often and u suspect this is the way of the future.
#liversky
May 9, 2025 at 3:11 PM
Highlights of @docberza.bsky.social talk on NITs @easlnews.bsky.social #easlcongress
We need to use @bavenocoop.bsky.social
dual stiffness cutoffs more often and u suspect this is the way of the future.
#liversky
We need to use @bavenocoop.bsky.social
dual stiffness cutoffs more often and u suspect this is the way of the future.
#liversky
Reposted by Brett E Fortune
That’s a wrap on #EASLCongress2025! 💙 Thanks to all 7,742 attendees from 119 countries and all those who made this event possible! 🌍
See you in Barcelona on 27–30 May 2026!
Look back at the unforgettable moments easl.smugmug.com/EASL-Congres...
Best of slide decks: easlcampus.eu/Documents/be...
See you in Barcelona on 27–30 May 2026!
Look back at the unforgettable moments easl.smugmug.com/EASL-Congres...
Best of slide decks: easlcampus.eu/Documents/be...
May 10, 2025 at 1:06 PM
That’s a wrap on #EASLCongress2025! 💙 Thanks to all 7,742 attendees from 119 countries and all those who made this event possible! 🌍
See you in Barcelona on 27–30 May 2026!
Look back at the unforgettable moments easl.smugmug.com/EASL-Congres...
Best of slide decks: easlcampus.eu/Documents/be...
See you in Barcelona on 27–30 May 2026!
Look back at the unforgettable moments easl.smugmug.com/EASL-Congres...
Best of slide decks: easlcampus.eu/Documents/be...
Reposted by Brett E Fortune
📃 5 new EASL CPGs released today at
#EASLCongress!
✅ Make sure to attend the much awaited sessions listed below!
#EASLCongress!
✅ Make sure to attend the much awaited sessions listed below!
May 10, 2025 at 6:51 AM
📃 5 new EASL CPGs released today at
#EASLCongress!
✅ Make sure to attend the much awaited sessions listed below!
#EASLCongress!
✅ Make sure to attend the much awaited sessions listed below!
Reposted by Brett E Fortune
One need not worry about bleeding when banding varices in patients with low platelets
I am not sure why this study excluded people with platelets less than 30
Nevertheless … doi.org/10.3390/dise...
#liversky
I am not sure why this study excluded people with platelets less than 30
Nevertheless … doi.org/10.3390/dise...
#liversky
March 2, 2025 at 5:12 PM
One need not worry about bleeding when banding varices in patients with low platelets
I am not sure why this study excluded people with platelets less than 30
Nevertheless … doi.org/10.3390/dise...
#liversky
I am not sure why this study excluded people with platelets less than 30
Nevertheless … doi.org/10.3390/dise...
#liversky
Reposted by Brett E Fortune
Trends in authorship in GI and Hepatology journals
From Tsai et al in Hep Comm
journals.lww.com/hepcomm/full...
@brettefortune.bsky.social
From Tsai et al in Hep Comm
journals.lww.com/hepcomm/full...
@brettefortune.bsky.social
February 27, 2025 at 11:29 PM
Trends in authorship in GI and Hepatology journals
From Tsai et al in Hep Comm
journals.lww.com/hepcomm/full...
@brettefortune.bsky.social
From Tsai et al in Hep Comm
journals.lww.com/hepcomm/full...
@brettefortune.bsky.social
Reposted by Brett E Fortune
This paper from @neeharparikh.bsky.social rocked
He asked patients what they want most in a liver cancer screening test using a discrete choice-based conjoint survey
pubmed.ncbi.nlm.nih.gov/33618022/
#liversky
He asked patients what they want most in a liver cancer screening test using a discrete choice-based conjoint survey
pubmed.ncbi.nlm.nih.gov/33618022/
#liversky
February 17, 2025 at 1:35 AM
This paper from @neeharparikh.bsky.social rocked
He asked patients what they want most in a liver cancer screening test using a discrete choice-based conjoint survey
pubmed.ncbi.nlm.nih.gov/33618022/
#liversky
He asked patients what they want most in a liver cancer screening test using a discrete choice-based conjoint survey
pubmed.ncbi.nlm.nih.gov/33618022/
#liversky
Reposted by Brett E Fortune
The rates and reasons for ethics consultation in cirrhosis care
0.2% incidence
Mainly due to issues of surrogate decision making and miscommunication
#liversky
trebuchet.public.springernature.app/get_content/...
0.2% incidence
Mainly due to issues of surrogate decision making and miscommunication
#liversky
trebuchet.public.springernature.app/get_content/...
trebuchet.public.springernature.app
February 8, 2025 at 11:57 PM
The rates and reasons for ethics consultation in cirrhosis care
0.2% incidence
Mainly due to issues of surrogate decision making and miscommunication
#liversky
trebuchet.public.springernature.app/get_content/...
0.2% incidence
Mainly due to issues of surrogate decision making and miscommunication
#liversky
trebuchet.public.springernature.app/get_content/...
Reposted by Brett E Fortune
February 6, 2025 at 1:11 AM
Reposted by Brett E Fortune
Early Terli
Giving terlipressin at lower creatinines (1.5-2.0) or within 12 hours of presentation (skipping the “albumin challenge”)
1. From the RCTs journals.lww.com/hepcomm/page...
2. Pilot trial doi.org/10.1007/s106...
#liversky
Giving terlipressin at lower creatinines (1.5-2.0) or within 12 hours of presentation (skipping the “albumin challenge”)
1. From the RCTs journals.lww.com/hepcomm/page...
2. Pilot trial doi.org/10.1007/s106...
#liversky
Image Gallery : Early treatment with terlipressin in patients with hepatorenal syndrome yields improved clinical outcomes in North American studies : Hepatology Communications
journals.lww.com
December 23, 2024 at 12:15 AM
Early Terli
Giving terlipressin at lower creatinines (1.5-2.0) or within 12 hours of presentation (skipping the “albumin challenge”)
1. From the RCTs journals.lww.com/hepcomm/page...
2. Pilot trial doi.org/10.1007/s106...
#liversky
Giving terlipressin at lower creatinines (1.5-2.0) or within 12 hours of presentation (skipping the “albumin challenge”)
1. From the RCTs journals.lww.com/hepcomm/page...
2. Pilot trial doi.org/10.1007/s106...
#liversky
Reposted by Brett E Fortune
Amid recurrent outbreaks of Ebola virus disease, the role of ring vaccination with the rVSV-ZEBOVGP vaccine during the 2018–2020 outbreak in Democratic Republic of Congo offers evidence of efficacy. Full study results: nej.md/4iFCWTL
#MedSky #IDSky
#MedSky #IDSky
Ebola Outbreak Response in the DRC with rVSV-ZEBOV-GP Ring Vaccination | NEJM
At the beginning of the 2018–2020 outbreak of Ebola virus disease (EVD) in eastern
Democratic Republic of Congo (DRC), no vaccine had been licensed. However, cluster-randomized
evidence from Guinea...
nej.md
December 21, 2024 at 8:06 PM
Amid recurrent outbreaks of Ebola virus disease, the role of ring vaccination with the rVSV-ZEBOVGP vaccine during the 2018–2020 outbreak in Democratic Republic of Congo offers evidence of efficacy. Full study results: nej.md/4iFCWTL
#MedSky #IDSky
#MedSky #IDSky
Reposted by Brett E Fortune
Fibrates and other PPAR agonists are so hot right now
Here is a review of how they work, the evidence of benefit, and the bright future of this pathway in improving liver health
journals.lww.com/hepcomm/full...
Here is a review of how they work, the evidence of benefit, and the bright future of this pathway in improving liver health
journals.lww.com/hepcomm/full...
PPAR agonists for the treatment of cholestatic liver... : Hepatology Communications
and the risk of progression to cirrhosis and liver failure. First-line therapy for PBC is ursodeoxycholic acid, although up to 40% of treated individuals are incomplete responders, and there is no eff...
journals.lww.com
December 20, 2024 at 1:13 AM
Fibrates and other PPAR agonists are so hot right now
Here is a review of how they work, the evidence of benefit, and the bright future of this pathway in improving liver health
journals.lww.com/hepcomm/full...
Here is a review of how they work, the evidence of benefit, and the bright future of this pathway in improving liver health
journals.lww.com/hepcomm/full...
Reposted by Brett E Fortune
Updated HCC management guidelines by @easlnews.bsky.social
Must read 👇🏼👇🏼👇🏼
www.journal-of-hepatology.eu/article/S016...
#Liversky
Must read 👇🏼👇🏼👇🏼
www.journal-of-hepatology.eu/article/S016...
#Liversky
December 17, 2024 at 12:48 PM
Updated HCC management guidelines by @easlnews.bsky.social
Must read 👇🏼👇🏼👇🏼
www.journal-of-hepatology.eu/article/S016...
#Liversky
Must read 👇🏼👇🏼👇🏼
www.journal-of-hepatology.eu/article/S016...
#Liversky
Reposted by Brett E Fortune
Brilliant test developed by Professor Maja Thiele
LiverPRO identifies
✅clinically significant liver fibrosis
✅ ⬆️ liver stiffness
✅predicts risk of liver-related events
based on age and biochemical variables
#liversky
www.sciencedirect.com/science/arti...
Development, validation, and prognostic evaluation of LiverPRO for the prediction of significant liver fibrosis in primary care: a prospective cohort study
Clinically significant liver fibrosis is associated with future adverse events in patients with steatotic liver disease. We designed a software tool f…
www.sciencedirect.com
December 12, 2024 at 11:49 PM
Brilliant test developed by Professor Maja Thiele
LiverPRO identifies
✅clinically significant liver fibrosis
✅ ⬆️ liver stiffness
✅predicts risk of liver-related events
based on age and biochemical variables
#liversky
www.sciencedirect.com/science/arti...
Reposted by Brett E Fortune
🧵 Combination Therapy for Chronic HBV Infection (a thread)
Chronic hepatitis B virus (HBV) affects more than 3% of the world population and is responsible for approximately 1.1 million deaths annually.
Full article: nej.md/49nfu9F 1/15
#MedSky
Chronic hepatitis B virus (HBV) affects more than 3% of the world population and is responsible for approximately 1.1 million deaths annually.
Full article: nej.md/49nfu9F 1/15
#MedSky
December 9, 2024 at 7:43 PM
🧵 Combination Therapy for Chronic HBV Infection (a thread)
Chronic hepatitis B virus (HBV) affects more than 3% of the world population and is responsible for approximately 1.1 million deaths annually.
Full article: nej.md/49nfu9F 1/15
#MedSky
Chronic hepatitis B virus (HBV) affects more than 3% of the world population and is responsible for approximately 1.1 million deaths annually.
Full article: nej.md/49nfu9F 1/15
#MedSky
Reposted by Brett E Fortune
I recommend this review on muscle cramps in #cirrhosis
Cramps are common and are the number one symptom priority for many patients
doi.org/10.1111/apt....
But ….
Cramps are common and are the number one symptom priority for many patients
doi.org/10.1111/apt....
But ….
Management of Muscle Cramps in Patients With Cirrhosis: A Systematic Review of Randomised Controlled Trials
Despite the prevalence and quality of life impact cramps have on patients with cirrhosis, no widely used clinical practice guidelines on management exist. Our systematic review, focusing only on rand...
doi.org
November 24, 2024 at 9:32 PM
I recommend this review on muscle cramps in #cirrhosis
Cramps are common and are the number one symptom priority for many patients
doi.org/10.1111/apt....
But ….
Cramps are common and are the number one symptom priority for many patients
doi.org/10.1111/apt....
But ….
Reposted by Brett E Fortune
🎨 In case anyone need…
The NIH BioArt Source is an awesome library of *free* professionally drawn illustrations for scientific presentations or figures. Downloadable in HD. Thank you NIH for this invaluable tool 🙏!
Check it out 👇
bioart.niaid.nih.gov
The NIH BioArt Source is an awesome library of *free* professionally drawn illustrations for scientific presentations or figures. Downloadable in HD. Thank you NIH for this invaluable tool 🙏!
Check it out 👇
bioart.niaid.nih.gov
November 23, 2024 at 3:50 PM
🎨 In case anyone need…
The NIH BioArt Source is an awesome library of *free* professionally drawn illustrations for scientific presentations or figures. Downloadable in HD. Thank you NIH for this invaluable tool 🙏!
Check it out 👇
bioart.niaid.nih.gov
The NIH BioArt Source is an awesome library of *free* professionally drawn illustrations for scientific presentations or figures. Downloadable in HD. Thank you NIH for this invaluable tool 🙏!
Check it out 👇
bioart.niaid.nih.gov
Reposted by Brett E Fortune
💊 New exciting multi-centre RCT (BALANCE) in NEJM supporting that an antibiotic duration of 7 days is non-inferior to 14 days in patients with uncomplicated bacteremia (excluding S. aureus). #MedSky #IMsky #IDsky
Good news! Across 74 hospitals in 7 countries, hosp patients with bloodstream infection, did just as well with antibiotic treatment for 7 days vs 14 days! @NEJM
www.nejm.org/doi/full/10....
#MedSky #MedTwitter 🧪 #EMSky #EMedSky #BlueSky
#MedEd #IDSky #fmsky #pedsky #nursesky
www.nejm.org/doi/full/10....
#MedSky #MedTwitter 🧪 #EMSky #EMedSky #BlueSky
#MedEd #IDSky #fmsky #pedsky #nursesky
Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections | NEJM
Bloodstream infections are associated with substantial morbidity and mortality. Early,
appropriate antibiotic therapy is important, but the duration of treatment is uncertain.
In a multicenter, non...
www.nejm.org
November 24, 2024 at 12:55 AM
Reposted by Brett E Fortune
#LiverSky: Performing early diagnostic paracentesis within 12 hours of admission may offer the greatest survival benefit.
Share your thoughts on implementing this into practice!
The American Journal of Gastroenterology #RedJournal
@amcollegegastro.bsky.social
🔗 journals.lww.com/ajg/pages/ar...
Share your thoughts on implementing this into practice!
The American Journal of Gastroenterology #RedJournal
@amcollegegastro.bsky.social
🔗 journals.lww.com/ajg/pages/ar...
November 23, 2024 at 6:22 PM
#LiverSky: Performing early diagnostic paracentesis within 12 hours of admission may offer the greatest survival benefit.
Share your thoughts on implementing this into practice!
The American Journal of Gastroenterology #RedJournal
@amcollegegastro.bsky.social
🔗 journals.lww.com/ajg/pages/ar...
Share your thoughts on implementing this into practice!
The American Journal of Gastroenterology #RedJournal
@amcollegegastro.bsky.social
🔗 journals.lww.com/ajg/pages/ar...
Reposted by Brett E Fortune
Thanks to HEPATOLOGY journal for this special issue on alcohol-associated liver disease & the chance to review this alarming global crisis 🚨🌎: >11M life-years lost annually, leading cause of liver Tx, and rising impact on young people
🙏 Amazing author team⭐️
journals.lww.com/hep/fulltext...
🙏 Amazing author team⭐️
journals.lww.com/hep/fulltext...
Alcohol-associated liver disease—Global epidemiology : Hepatology
ty-adjusted life-years attributed to ALD, particularly pronounced in the United States, are alarming. Projections suggest that the economic impact of ALD, as seen in the United States, could potential...
journals.lww.com
November 17, 2024 at 6:04 PM
Thanks to HEPATOLOGY journal for this special issue on alcohol-associated liver disease & the chance to review this alarming global crisis 🚨🌎: >11M life-years lost annually, leading cause of liver Tx, and rising impact on young people
🙏 Amazing author team⭐️
journals.lww.com/hep/fulltext...
🙏 Amazing author team⭐️
journals.lww.com/hep/fulltext...
Super helpful!! Thanks #LiverSky @ebtapper.bsky.social
We keep growing!
We are on our second starter pack for GI / Hepatology
Part 1: go.bsky.app/8Pho2tp
Part 2: go.bsky.app/VGyLKjR
#medsky #GIsky #LiverSky
Part 1: go.bsky.app/8Pho2tp
Part 2: go.bsky.app/VGyLKjR
#medsky #GIsky #LiverSky
November 24, 2024 at 12:08 AM
Super helpful!! Thanks #LiverSky @ebtapper.bsky.social